Literature DB >> 20703524

Integrating clinical information in National Biobank of Korea.

Hangchan Kim1, Byoung-Kee Yi, Il Kon Kim, Yun Sik Kwak.   

Abstract

The National Biobank of Korea (NBK) is a government supported project that aims at consolidating various human-originated biomedical resources collected by individual hospitals nation-wide and integrating them with their donors' clinical information which researchers can take advantage of. In this paper, we present our experiences in developing the Clinical Information Integration System (CIIS) for NBK. The system automatically extracts clinical data from hospital information systems as much as possible to avoid errors from manual entry by human errors. It maintains the independence of individual hospitals by employing a two-layer approach, one of which takes care of all hospital-specific aspects. Interoperability is achieved by adopting HL7 v2.x messaging between the biobank and hospitals. We report the current status of the biobank and system deployments. We finally identify limitations and discuss how to improve them.

Entities:  

Mesh:

Year:  2009        PMID: 20703524     DOI: 10.1007/s10916-009-9402-6

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  16 in total

Review 1.  The BioBank Japan Project.

Authors:  Yusuke Nakamura
Journal:  Clin Adv Hematol Oncol       Date:  2007-09

Review 2.  Biobanking for Europe.

Authors:  Martin Yuille; Gert-Jan van Ommen; Christian Bréchot; Anne Cambon-Thomsen; Georges Dagher; Ulf Landegren; Jan-Eric Litton; Markus Pasterk; Leena Peltonen; Mike Taussig; H-Erich Wichmann; Kurt Zatloukal
Journal:  Brief Bioinform       Date:  2007-10-23       Impact factor: 11.622

3.  The federated database--a basis for biobank-based post-genome studies, integrating phenome and genome data from 600,000 twin pairs in Europe.

Authors:  Juha Muilu; Leena Peltonen; Jan-Eric Litton
Journal:  Eur J Hum Genet       Date:  2007-05-09       Impact factor: 4.246

Review 4.  TuBaFrost 4: access rules and incentives for a European tumour bank.

Authors:  J A Lopez-Guerrero; P H J Riegman; J W Oosterhuis; K H Lam; M H A Oomen; A Spatz; C Ratcliffe; K Knox; R Mager; D Kerr; F Pezzella; B van Damme; M van de Vijver; H van Boven; M M Morente; S Alonso; D Kerjaschki; J Pammer; A Carbone; A Gloghini; I Teodorovic; M Isabelle; A Passioukov; S Lejeune; P Therasse; E-B van Veen; W N M Dinjens; A Llombart-Bosch
Journal:  Eur J Cancer       Date:  2006-10-05       Impact factor: 9.162

5.  The biobank of the Norwegian Mother and Child Cohort Study: a resource for the next 100 years.

Authors:  Kjersti S Rønningen; Liv Paltiel; Helle M Meltzer; Rannveig Nordhagen; Kari K Lie; Ragnhild Hovengen; Margaretha Haugen; Wenche Nystad; Per Magnus; Jane A Hoppin
Journal:  Eur J Epidemiol       Date:  2006-09-20       Impact factor: 8.082

Review 6.  Biobanking for better healthcare.

Authors:  Peter H J Riegman; Manuel M Morente; Fay Betsou; Pasquale de Blasio; Peter Geary
Journal:  Mol Oncol       Date:  2008-07-30       Impact factor: 6.603

7.  Biobanks: transnational, European and global networks.

Authors:  Martin Asslaber; Kurt Zatloukal
Journal:  Brief Funct Genomic Proteomic       Date:  2007-10-04

Review 8.  A human tissue and data resource: an overview of opportunities, challenges, and development of a provider/researcher partnership model.

Authors:  Eric J Kort; Bryon Campbell; James H Resau
Journal:  Comput Methods Programs Biomed       Date:  2003-02       Impact factor: 5.428

Review 9.  Tumour banks: well-guarded treasures in the interest of patients.

Authors:  J Wolter Oosterhuis; Jan Willem Coebergh; Evert-Ben van Veen
Journal:  Nat Rev Cancer       Date:  2003-01       Impact factor: 60.716

10.  OECI TuBaFrost tumor biobanking.

Authors:  Peter H J Riegman; Antonio Llombart Bosch
Journal:  Tumori       Date:  2008 Mar-Apr
View more
  1 in total

1.  The "DGPPN-Cohort": A national collaboration initiative by the German Association for Psychiatry and Psychotherapy (DGPPN) for establishing a large-scale cohort of psychiatric patients.

Authors:  Heike Anderson-Schmidt; Lothar Adler; Chadiga Aly; Ion-George Anghelescu; Michael Bauer; Jessica Baumgärtner; Joachim Becker; Roswitha Bianco; Thomas Becker; Cosima Bitter; Dominikus Bönsch; Karoline Buckow; Monika Budde; Martin Bührig; Jürgen Deckert; Sara Y Demiroglu; Detlef Dietrich; Michael Dümpelmann; Uta Engelhardt; Andreas J Fallgatter; Daniel Feldhaus; Christian Figge; Here Folkerts; Michael Franz; Katrin Gade; Wolfgang Gaebel; Hans-Jörgen Grabe; Oliver Gruber; Verena Gullatz; Linda Gusky; Urs Heilbronner; Krister Helbing; Ulrich Hegerl; Andreas Heinz; Tilman Hensch; Christoph Hiemke; Markus Jäger; Anke Jahn-Brodmann; Georg Juckel; Franz Kandulski; Wolfgang P Kaschka; Tilo Kircher; Manfred Koller; Carsten Konrad; Johannes Kornhuber; Marina Krause; Axel Krug; Mahsa Lee; Markus Leweke; Klaus Lieb; Mechthild Mammes; Andreas Meyer-Lindenberg; Moritz Mühlbacher; Matthias J Müller; Vanessa Nieratschker; Barbara Nierste; Jacqueline Ohle; Andrea Pfennig; Marlenna Pieper; Matthias Quade; Daniela Reich-Erkelenz; Andreas Reif; Markus Reitt; Bernd Reininghaus; Eva Z Reininghaus; Matthias Riemenschneider; Otto Rienhoff; Patrik Roser; Dan Rujescu; Rebecca Schennach; Harald Scherk; Max Schmauss; Frank Schneider; Alexandra Schosser; Björn H Schott; Sybille G Schwab; Jens Schwanke; Daniela Skrowny; Carsten Spitzer; Sebastian Stierl; Judith Stöckel; Susanne Stübner; Andreas Thiel; Hans-Peter Volz; Martin von Hagen; Henrik Walter; Stephanie H Witt; Thomas Wobrock; Jürgen Zielasek; Jörg Zimmermann; Antje Zitzelsberger; Wolfgang Maier; Peter G Falkai; Marcella Rietschel; Thomas G Schulze
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-04-03       Impact factor: 5.270

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.